Zobrazeno 1 - 10
of 349
pro vyhledávání: '"synergistic antitumor"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Tumors are still a major threat to people worldwide. Nanodrug delivery and targeting systems can significantly improve the therapeutic efficacy of chemotherapeutic drugs for antitumor purposes. However, many nanocarriers are likely to exhibit drawbac
Externí odkaz:
https://doaj.org/article/68d832195fab4ce9880e794dbfb43077
Publikováno v:
PeerJ, Vol 11, p e15942 (2023)
Background In this study, a natural compound quercetin (Qu) was investigated for its various antitumor effects. However, due to its poor water solubility and low bioavailability, its clinical application is limited. To overcome this constraint, a mod
Externí odkaz:
https://doaj.org/article/f99bbbd331604f6babf923ac6654c64a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
International Journal of Nanomedicine, Vol Volume 17, Pp 617-633 (2022)
Bowei Chen,1,* Xiaohong Liu,1,* Yunan Li,1 Tianhe Shan,1 Liya Bai,1 Chunyu Li,2 Yinsong Wang1 1School of Pharmacy, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), Tianjin Me
Externí odkaz:
https://doaj.org/article/749c2a3a97c2475c95769e5827764cea
Publikováno v:
International Journal of Nanomedicine, Vol Volume 18, Pp 2819-2820 (2023)
Li L, Chen Y, Wang Q, et al. Int J Nanomedicine. 2021;16:5513–5529. It has been brought to the authors attention that the control groups of antitumor activities in vivo overlapped with those from the authors previously published article, Chen Y, Wa
Externí odkaz:
https://doaj.org/article/b7358ce787e842ac9c9157dbc1866b44
Publikováno v:
International Journal of Nanomedicine, Vol Volume 16, Pp 5513-5529 (2021)
Linming Li,1,* Yan Chen,1,* Qingpeng Wang,1 Zuojie Li,1 Zhifang Liu,1 Xuewen Hua,1 Jun Han,1 Chunxiao Chang,2 Zhengping Wang,1,3 Dacheng Li1,4 1Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng, 252059, People’s Repub
Externí odkaz:
https://doaj.org/article/53f5816f5fd1468bbb3dc3056b9dff01
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-33 (2021)
Abstract As competitive HMG-CoA reductase (HMGCR) inhibitors, statins not only reduce cholesterol and improve cardiovascular risk, but also exhibit pleiotropic effects that are independent of their lipid-lowering effects. Among them, the anti-cancer
Externí odkaz:
https://doaj.org/article/9beb19ece1274720b402642059ffe964
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1217 (2023)
Tumor microenvironment (TME)-induced nanocatalytic therapy is a trending strategy for tumor-targeting therapy, but the low catalytic efficiency remains to limit its therapeutic effect. The single-atom catalysts (SACs) appear as a novel type of nanozy
Externí odkaz:
https://doaj.org/article/9ec21a7b4fac401da6ad28e74acb80b5
Autor:
Xiao-Chuan Duan, Li-Yuan Peng, Xin Yao, Mei-Qi Xu, Hui Li, Shuai-Qiang Zhang, Zhuo-Yue Li, Jing-Ru Wang, Zhen-Han Feng, Guang-Xue Wang, Ai Liao, Ying Chen, Xuan Zhang
Publikováno v:
Drug Delivery, Vol 28, Iss 1, Pp 800-813 (2021)
Cancer immunotherapy is a strategy that is moving to the frontier of cancer treatment in the current decade. In this study, we show evidence that 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs), act as immunogenic cell death
Externí odkaz:
https://doaj.org/article/833feb7b030d426a96d2efbd4c05e78f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.